STOCKS TELEGRAPH

Author: ST Staff

  • PolyMet Mining Corp. (PLM) Stock Exhibits Minor Volatility as Mining Permit for Project is Halted

    PolyMet Mining Corp. (PLM) Stock Exhibits Minor Volatility as Mining Permit for Project is Halted

    PolyMet Mining Corp. (PLM) stock prices were up by 1.34% as of the market closing on June 18th 2021, bringing the price per share up to USD$3.77. After-hours trading saw the stock fall by 5.57%, bringing it down to USD$3.56.

    Devastating EPA Decision

    The company announced on June 4th, 2021 that the Environmental Protection Agency (EPA) had reached the conclusion that PLM’s proposed project to mine copper, nickel, and other precious metals had the potential to affect its surrounding areas. The primary area of concern was the water network on the Fond du Lac reservation and in Wisconsin, both of which are more than 100 miles downstream of the mining sites.

    Questioning the Decision

    The EPA’s conclusion does not imply that the company’s mining activities will result in adverse effects on downstream water quality, just that such an effect is possible. This is a direct contradiction of the 2018 Minnesota Pollution Control Agency’s certification that the project would not affect in-state water quality, under section 401 of the Clean Water Act. The company plans to present evidence that the MCPA conveyed to the Army Corps of Engineers, likely resulting in the requirement of a hearing to make a final decision in regard the matter.

    Basis for Doubt

    During its operation, the project will collect and treat water, resulting in a net reduction of contaminants in the St. Louis River system. This includes water that hold mercury, among other contaminants, from previous mining of taconite in the area. The company has expressed grave concerns about the conclusion reached by the EPA, citing the disconnect between meeting standards of quality close to the source of the discharge while failing to do so for locals much further downstream. These concerns are compounded by the likelihood of the project resulting in reduced overall mercury loading to the river.

    Challenging the EPA

    Backed by science that supports the development of the project, the company is determined to work with both the EPA and Corps to rectify the issue so development can continue. Because the EPA needs to approve projects for downstream water quality for the issuance of a section 404 wetlands permit, PLM is keen to accelerate the process. The Corps has placed the permit on old during the review and is likely to stay in place until a resolution to the dilemma.

    Future Outlook for PLM

    Confident of the regulatory integrity of their project, PLM is determined to challenge the devastating EPA evaluation. The company is keen to continue its trajectory of success and usher in unprecedented growth with the advancement of its mining project. Current and potential investors are hopeful that management will leverage the resources at their disposal to facilitate significant and sustained increases in shareholder value.

  • What Drove The Sphere 3D (ANY) Stock Higher In Extended Trades?

    Last checked, shares of Sphere 3D Corp. (ANY) were trading at $2.25 after hours, up 1.81%. A loss of -5.15% pushed the Sphere 3D stock price to $2.21 at the end of Friday’s session. The total number of shares traded decreased to 1.25 million shares from 6.51 million shares within the past 50 days. Shares of Sphere 3D have moved down by -17.54% over the past week and by -13.67% over the last year.

    ANY Stock has lost -25.08% over the last three months, and 49.32% over the past six months. Furthermore, Sphere 3D is currently worth $45.9 million and has 9.42 million outstanding shares. It seems that ANY stock has recovered in the after-hours trades after dropping in the regular session.

    What caused ANY stock to fluctuate?

    In addition to its HVE ConneXions brand, Sphere 3D also offers UCX ConneXions and SnapServer, which all help clients reach their IT goals. As part of their recently signed agreement and plan of merger, Sphere 3D and Gryphon Digital Mining have each committed to purchasing 125,000 Certified Emission Reduction (CERs) credits.

    • Gryphon will become the first crypto miner to become carbon negative by taking advantage of these credits, as well as supporting ESG commitments.
    • Gryphon and Sphere 3D are expanding their sustainable and environmental stewardship efforts.
    • Sphere 3D and Gryphon are estimated to remain carbon-negative for at least the next five years based on their current operations.
    • Despite the fact that Gryphon’s core business uses only renewable energy, it acknowledges that it has a nonexistent carbon footprint.
    • The carbon offset credits will be used for the global transportation of cryptocurrency mining machines, employee travel for company meetings, as well as miscellaneous emissions from staff travel and meals.

    Sphere 3D’s recent strategic move:

    Recently, Sphere 3D (ANY) signed an Agreement and Plan of Merger with Gryphon Digital Mining Inc, a privately-held company that specializes in bitcoin mining through renewable energy.

    • After the merger has been completed, Sphere 3D’s name will change to Gryphon Digital Mining Inc.
    • The merged company will focus on expanding Gryphon’s digital mining operations as well as optimizing its operations with Sphere 3D’s proprietary enterprise solutions.
    • A total of 111,000,000 common shares of Sphere 3D stock will be distributed to the shareholder of Gryphon upon completion of the Merger.
    • The board of directors of both companies has approved the transaction.
    • Sphere 3D expects that the merger will close in the third quarter of 2021.
  • Zymeworks, Inc. (ZYME) Stock Undergoes Minor Volatility AsZanidatamab Development Continues

    Zymeworks, Inc. (ZYME) Stock Undergoes Minor Volatility AsZanidatamab Development Continues

    Zymeworks, Inc. (ZYME) stock prices were down by 5.05% as of the market closing on June 18th, 2021, bringing the price per share down to USD$36.25 at the end of the trading day. After-hours trading saw the stock climb by 7.56%, bringing it up to USD$38.99.

    Zanidatamab Development

    The company continues to enroll patients for its global pivotal trial for zanidatamab, a HER2-targeted bispecific antibody, monotherapy for patients previously treated HER2 gene-amplified BTC (HerIZON-BTC-01. Enrolment is continuing throughout sites across North and South America, Europe, and Asia, with the trial having been initiate based on encouraging data. This data highlighted a 40% confirmed objective response rate for zanidatamab monotherapy in BTC. The development of the treatment has been supported by various special designations in the U.S and EU.

    FDA Clearance

    ZYME also recently received clearance from the U.S Food and Drug Administration for the first randomized Phase 3 clinical trial for zanidatamab. HeriZON-GEA-01 is a randomized study of zanidatamab that is conducted across multiple centers, in combination with chemotherapy with or without BeiGene’s PD-1 targeted antiboy, tislelizumab. The regimen is designed as a first line treatment for patients with HER2-positive unrespectable locally advanced or metastatic GEA. Clinical data that supports the study from an ongoing Phase 2 clinical trial evaluating zanidatamab is expected to be presented in the second half of 2021.

    Presenting Zanidatamab Data

    April saw the presentation of preclinical data at the American Association for Cancer Research, which will reveal new insights into the unique mechanisms of action of zanidatamab. The presentation will also facilitate the introduction of the company’s fourth therapeutic platform, ProTECT, as well as describe two new preclinical assets focused on both the cykotine, IL-12, and the immune-oncology target, 4-1BB.

    Revenue Reports

    Revenue for the quarter ended March 31st, 2021 was reported at USD$0.6 million, down from the USD$8.3 million reported for the same quarter of the prior year. The revenue for 2021 was primarily related to support for research from partners. The massive year-over-year difference is largely attributable to the USD$5 million from BeiGene for a development milestone and USD$3.3 million from our partners for research support, drug supply, and other payments.

    Future Outlook for ZYME

    Armed with the continued development of zanidatamab, ZYME is poised to continue its trajectory of success. The company is keen to push for the commercialization and proliferation of its flagship treatment to usher in continued growth. Current and potential investors are hopeful that management will leverage the resources at their disposal to facilitate significant and sustained increases in shareholder value.

  • Here is why Salem Media Group Inc (SALM) stock rallied in the after-hours on Friday?

    Here is why Salem Media Group Inc (SALM) stock rallied in the after-hours on Friday?

    Salem Media Group Inc. (SALM) shares gained 10.78% in after-hours on Friday, June 18, 2021, and closed the weekly trading at $2.57 per share. Earlier in the morning session, SALM’s stock lost 0.85% to close Friday’s session at $2.32 per share. SALM shares have risen 43.21% over the last 12 months, and they have moved down by 10.77% in the past week. Over the past three months, the stock has lost 21.36%, while over the past six months, it has declined 118.87%.

    Let’s have a look at its recent developments.

    Partnership with Dinesh D’Souza

    On June 17, 2021, Salem Media Group, Inc partnered with noted film director Dinesh D’Souza on a new documentary, to silence the views they disagree with on the right has led to the new documentary, produced by D’Souza and Salem Media Group. The film, tentatively titled “Silenced” is set to release in mid of 2022.

    New Marketing Venture

    On June 15, 2021, the sales division of Salem Media Group, which is also known as Salem Media Representativesformed the Salem Influencer Network to focus on connecting brands with the fans of leading Christian social media influencers.

    The new entry to Salem Podcast Network

    On June 2, 2021, Salem Media Group, Inc added Trish Regan to the podcast lineup of the Salem Podcast Network (SPN), beginning June 15th. SPN has grown into the top 15 of all podcast networks in the USA, with over 2.5 million average weekly downloads within only short 6 months of its existence.

    Participation in Noble Capital Markets C-Suite Interview Series

    On May 26, 2021, Salem Media Group announced that it participated in Noble Capital Markets’ C-Suite Interview Series, presented by Channelchek. Executive Vice President and Chief Financial Officer Evan Masyr talked with Noble Capital Markets Senior Research Analyst Michael Kupinski for this exclusive interview.

    Recent Financial results

    On May 7, 2021, Salem Media Group announced its financial results for the three months ended March 31, 2021.

    Q1 2021 financial highlights

    • Salem Media Group earned a revenue of 4 million in Q1 2021 compared to $58.3 million in Q1 2020.
    • For Q1 2021, total operating expenses were $55.0 million compared to $76.3 million in Q1 2020.
    • In Q1 2021, Operating income was $4.4 million compared to an operating loss of $18.0 million in Q1 2020.
    • The company had a net income of $0.3 million, or $0.01 net income per diluted share in Q1 2021 compared to a net loss of $55.2 million, or $2.07 net loss per share in Q1 2020.
    • EBITDA was $7.5 million in Q1 2021 compared to a loss of $14.3 million in the prior-year same quarter.

    Conclusion

    The partnership announcement with Dinesh D’Souza was the reason behind its positive performance in the after-market on Friday and it can continue its positive momentum on Monday as well.

  • Why GlycoMimetics Inc. (GLYC) stock faced negativity on Friday?

    Why GlycoMimetics Inc. (GLYC) stock faced negativity on Friday?

    GlycoMimetics Inc. (GLYC) shares remained unchanged in after-hours on Friday, June 18, 2021, and close the week at $2.33 per share. earlier in the morning session of Friday, GLYC’s stock lost 4.51% to close Friday’s morning session at $2.33 per share. GLYC shares have fallen 22.85% over the last 12 months, and they have moved down 15.27% in the past week. Over the past three months, the stock has lost 32.46%, while over the past six months, it has plummeted 34.18%.

    Let’s see is there any recent news or development about GLYC?

    Participation in the health conference

    GlycoMimetics, Inc recently participated at the Jefferies 2021 Virtual Healthcare Conference, which held on June 3, 2021. The company’s overview was presented by Chief Executive Officer Rachel King in a virtual presentation format.

    Phase 2 Clinical trial of Uproleselan

    On May 26, 2021, GlycoMimetics, Inc announced that clinicians at Washington University School of Medicine in St. Louis have dosed the first patient in an investigator-sponsored trial (IST) assessinguproleselan as a prophylactic agent to reduce gastrointestinal (GI) toxicities associated with high-dose melphalan in autologous hematopoietic cell transplantation (auto-HCT) for multiple myeloma (MM).

    Recent financial results announcement

    On May 3, 2021, GlycoMimetics reported its financial results for the quarter ended March 31, 2021.

    Q1 2021 financial highlights

    • GlycoMimetics reported revenue of $1.055 million for Q1 2021 compared to $9.0 million in Q1 2020
    • Total costs and expenses were $15.34 million for Q1 2021 compared to $17.10 million for Q1 2020.
    • The company suffered an operating loss of $14.28 million in Q1 2021 compared with $8.1 million in Q1 2020.
    • Net loss and comprehensive loss was $14.27 million or $0.28 net loss per common share, basic and diluted for Q1 2021 compared with $7.66 million or $0.18 net loss per common share, basic and diluted in Q1 2020.
    • As of March 31, 2021, GlycoMimeticshad cash and cash equivalents of $132.5 million.

    Presentation of Positive Therapeutic Effects of GMI-1757

    GlycoMimetics, Inc did a poster presentation of an abstract at the American Association of Cancer Research (AACR) 2021 Annual Meeting, which held virtually on April 10-15 and May 17-21

    The poster presentation showed the results of a recent preclinical study on the therapeutic effects of GMI-1757.

    The study showed that GMI-1757 significantly improved anti-PD-L1 therapeutic activity in a pancreatic adenocarcinoma model. Results showed 50% partial regressions and an approximate 99% reduction of median tumour volume.

    Conclusion

    Well, as of this writing there is no recent news or development which could justify its poor performance on Friday. we hope that GLYC will commence the new week trading with positive momentum.

  • Here is why Globus Maritime Ltd (GLBS) stock ended the week on positive performance?

    Here is why Globus Maritime Ltd (GLBS) stock ended the week on positive performance?

    Globus Maritime Limited (GLBS) shares gained 13.64% in after-hours on Friday, June 18, 2021, and close the week at $5.75 per share. Earlier in the morning session on Friday, GLBS’s stock gained 0.80% to close the session at $5.06. GLBS shares have fallen 86.75% over the last 12 months, and they have moved down 2.69% in the past week. Over the past three months, the stock has gained 2.43%, while over the past six months, it has lost 16.23%.

    Let’s have a look at its recent news and developments.

    Recent financial results announcement

    On June 18, 2021, Globus Maritime Limited announced its unaudited consolidated operating and financial results for the quarter ended March 31, 2021.

    Q1 2021 financial highlights

    • Globus Maritime Limited reported revenue of $5.17 million for Q1 2021 compared to $2.3 million for Q1 2020
    • Adjusted EBITDA was $1.3 million in Q1 2021 compared to $1.6 million in Q1 2020.
    • The company suffered a comprehensive loss of $0.8 million or $0.11 basic and diluted loss per share in Q1 2021 compared to a total comprehensive loss of $9 million for the same period last year or $154.85 basic and diluted loss per share in Q1 2020.
    • The company had cash and bank balances and bank deposits (including restricted cash) of $53.1 million as of March 31, 2021, compared to $21.1 million on December 31, 2020.

    Delivery & charter of the M/V Diamond Globe

     

    On June 15, 2021, Globus Maritime Limited took delivery of the M/V “Diamond Globe”, a 2018-built “Eco” Kamsarmax dry bulk carrier it acquired for a purchase price of $27 million, which the Company previously announced on March 23, 2021.

    Now the Company’s fleet has seven dry bulk carriers with a total carrying capacity of 463,765 DWT.

    M/V Diamond Globe has been successfully charted to an unrelated third party at a daily rate of $27,250. The charter is expected to commence at the earliest on June 16, 2021, and has a minimum duration of four months. 

    Closing of $34.25 million loan

    On May 12, 2021, Globus Maritime Limited completed the refinancing of its six vessels through a Term Loan Facility with CIT Bank, and the majority proceeds of which were used to repay the Company’s loan facility with EnTrust Global’s Blue Ocean Fund. 

    Conclusion

    The financial results announcement on Friday was the reason behind its surging in the after-hours on Friday. we can expect GLBS to continue its momentum on Monday as well.

  • Here is why Hudson Capital Inc. (HUSN) stock surged in the after-hours on Friday?

    Here is why Hudson Capital Inc. (HUSN) stock surged in the after-hours on Friday?

    Hudson Capital Inc. (HUSN) shares surged 4.68% in after-hours on Friday, June 18, 2021, and closed the week at $3.80 per share. Earlier, HUSN’s stock lost 6.68% in the after-hours on Friday’s session and close the session at $3.63. HUSN shares have fallen 38.47% over the last 12 months, and they have moved up 7.08% in the past week. Over the past three months, the stock has gained 0.55%, while over the past six months, it has shed 24.74%.

    Completion of Google Cloud Integration

    On June 17, 2021, Hudson Capital Inc announced that FreightHub, Inc. (Fr8Hub), with which Hudson Capital has signed a definitive Merger Agreement, completed its Google Cloud integration, enhancing its big data analytics capabilities, strengthening its data security, and increasing its operational efficiency.

    Technology collaboration with RC Control

    On June 02, 2021, Hudson Capital Inc announced that FreightHub, Inc. (Fr8Hub with which Hudson Capital has signed a definitive Merger Agreement, is collaborating with RC Control to help alleviate one of the biggest challenges with US-Mexico cross border freight: seamless visibility.

    Recent financial results

    On May 18, 2021, FreightHub, Inc(Fr8Hub) with which Hudson Capital has signed a definitive Merger Agreement, reported its financial results for the three months ended March 31, 2021, in Hudson Capital’s amended Registration Statement on Form S-4 filed on May 18, 2021, with the SEC.

    Q1 2021 financial highlights

    • FreightHub reported revenue of $4.8 million for the first quarter of 2021compared to $1.5 million in the prior-year period.
    • The company had record sales of $4.8 million during Q1 2021.

    Non-compliance notice from Nasdaq

    Hudson Capital Inc received written notification on May 13, 2021, from The Nasdaq Stock Market LLC that it no longer meets Listing Rule 5550(b)(1).

    According to the Nasdaq rule, Hudson Capital had to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing. The Company reported in its last annual report Form 20-F for the period ended December 31, 2021, that its stockholders’ equity was $631,145.

    The exceptional increase in FreightHub’s customer base

    On April 30, 2021, FreightHub, Inc reported that its expanded customer base has resulted in Fr8Hub delivering more than 15,000 loads since its inception in 2015.

    Fr8Hub customers grew 155% from 130 in October 2020 to more than 330 in April 2021, including one of the world’s largest snack and food manufacturers and one of North America’s largest retailers.

    New Broker Portal

    On March 25, 2021, HUSN announced a merger agreement with FreightHub to launch its new Broker Portal. The new Broker Portal is which is now available to freight forwarders and brokers in the domestic and US-Mexico cross-border shipping markets. The CEO of Fr8Hub Javier Selgas said that Broker Portal will fulfil the systemic needs of brokers and forwarders.

    Conclusion

    The completion of Google could integration may or may not be the reason behind its turnaround on Friday. we hope that HUSN will commence the new week with the same positivity.

  • San Juan Basin Royalty Trust (SJT) Stock Dips Significantly Ahead of June 2021 Cash Distribution

    San Juan Basin Royalty Trust (SJT) stock prices were down by a concerning 15.38% shortly after market trading commenced on June 18th, 2021, bringing the price per share up to USD$4.72 early on in the trading day.

    June 2021 Cash Distribution

    The company announced on June 18th, 2021 that it had declared a monthly cash distribution of a total of USD$821,024.63 to holders of its units of beneficial interest. This comes out to USD$0.017615 per unit, derived mainly from estimated production during April 2021, subject to various adjustments by the owner of the Trust’s subject interests for prior months. The distribution will be applicable to unit holders of record as of June 30th, 2021, with the payout scheduled for July 15th, 2021.

    Comparative Reports

    As per information provided to the company by Hilcorp, April 2021 saw gas production for the subject interests coming out to a total of 2,498,553 Mcf, up from the 2,617,042 Mcf reported for the month of March in 2021. Average gas prices for April 2021 were calculated by dividing revenues by production volume, with a final figure of USD$1.67 per Mcf. This is comparable to an average gas price of USD$2.07 per Mcf for March 2021.

    April 2021 Breakdown

    Because of the company’s transition to a new accounting system, Hilcorp informed SJT that April 2021 would have a monthly report based on estimated production, estimated prices, and estimated costs. Revenue for the reporting month of April 2021 included an estimated USD$100,000 for non-operated revenue. Capital costs for the month of April 2021 came out to USD$11,623 as per Hilcorp reports to the trust. Lease operating expenses and property taxes were reported at USD$2,459,029, while severance taxes came in at USD$780,743.

    Capital Project Plan

    The company announced near the end of February that Hilcorp had provided the company with a capital project plan for the fiscal year 2021, which expected capital expenditures amounting to USD$0.3 million. The principal asset of the Trust is comprised of a 75% et overriding royalty interest that is derived from certain oil and gas leasehold and royalty interests in properties owned by Hilcorp. These interests stem from properties owned by Hilcorp in the San Juan Basin.

    Future Outlook for SJT

    Armed with a new accounting system, SJT is poised to capitalize on the opportunities afforded to it. The company is keen to bounce back from the dip in equity value following the cash distribution for June 2021. Current and potential investors are hopeful that management will continue to leverage the resources at their disposal to facilitate significant and sustained increases in shareholder value.

  • Here’s to know why Euro Tech Holdings Company Limited (CLWT) stock is rising today

    Here’s to know why Euro Tech Holdings Company Limited (CLWT) stock is rising today

    Euro Tech Holdings Company Limited (CLWT) stock announced a special cash dividend today on June 18, 2021, after which the CLWT stock price saw a push of 3.25% to reach $3.36 a share at the time of this writing. The stock is engaged in the distribution of water treatment equipment, laboratory-related accessories in the People’s Republic of China. Let’s discuss the recent event of CLWT stock in detail.

    What’s Happening?

    Euro Tech’s board of directors announced the dividend of $0.20 per ordinary share for shareholders who are under the list of shareholders as of June 28, 2021. The dividend will be paid in cash on July 06, 2021. American Stock Transfer and Trust LLC is appointed as the paying agent to administer the dividend process and no action is required by a shareholder to receive the dividend.

    Financial Year 2020 Results:

    Back to the previous month, Euro Tech announced the fiscal year 2020 results the highlights of which are given below.

    • The net income for CLWT stock in the fiscal year 2020 was US$769,000 as compared to US$146,000 net loss in 2019.
    • The revenue of the CLWT stock for the fiscal year reduced by 23.2% yearly from US$17,399,000 in 2019 to  US$13,357,000 in 2020. The decrease in the revenue was mainly due to COVID-19 escalation and the China-US tension in trade.
    • CLWT stock reported US$3,685,000 gross profit for the fiscal year 2020 which represents a 16.6%decrease as compared to gross profit of US$4,417,000 for 2019.
    • Euro-Tech spent US$5,374,000 in selling and administrative expenses in the year 2020 which represents a 10.7% increase.
    • The operating loss suffered by CLWT stock reached  US$1,701,000in the 12-month period of 2020, 41.5% higher than the US$440,000 operating loss in the fiscal year 2019.

    As of December 31, 2020, Euro Tech had cash and short-term investments of $3.52 million as compared to $5.99 million cash and short-term investments by the end of 2019.

    Ballast Water Treatment Systems (BWTS):

    Euro tech stock secured 4 sales contracts for BWTS along with some other port solutions in China in the last six months. Now the CLWT stock is near to complete the deal of supplying 8 sets of BWTS to ship owners in the Middle East and Southeast Asia.

    Conclusion:

    The announcement of a special cash dividend made the CLWT stock bullish today. The business was affected due to coronavirus escalations but as things are going back to normal, one should expect positive growth for CLWT stock.

  • Nemaura Medical Inc. (NMRD) Stock Poised to Recover as Global Immunization Efforts Accelerate

    Nemaura Medical Inc. (NMRD) Stock Poised to Recover as Global Immunization Efforts Accelerate

    Nemaura Medical Inc. (NMRD) stock prices were down by 5.20% as of the market closing on June 17th, 2021, bringing the price per share down to USD$10.57 at the end of the trading day. Subsequent pre-market fluctuations saw the stock rally by 1.89%, bringing it up to USD$10.77.

    GBA Review of sugarBEAT

    May 6th, 2021 saw the company announce the progress made with its attempt to achieve reimbursement for its sugarBEAT device from the German regulatory authority (GBA). After an initial review, the governing authority determined that there was no need for a GBA review of sugarBEAT. Instead, the device will be send directly to the National Association of Statutory Health Insurance Funds for a listing on the durable medical catalog.

    Penetrating German Market

    Currently, NMRD is completing the application for this listing, which will be significantly expedited in the absence of the need for a GBA review. The company continues to concentrate its efforts towards facilitating the commercial availability of its sugarBEAT device, with penetration of the German market marking a significant milestone for the company. To this end, the company continues to actively negotiate to identify the most suitable partner to take on the responsibility of marketing and distributing the product and program in such a crucial market.

    Huge Purchase Order

    May 5th, 2021 saw the company announce the receipt of a purchase order for 5000 of its sugarBEAT transmitters, as well as 200,000 of its sugarBEAT sensors. The order came through its U.K licensee, DB Ethitronix Ltd., with an additional rolling monthly purchase order expected. This rolling order will span a period of 24 months and will see the sale of 15000 transmitters and 2.1 million sensors. Included in the agreement will be an option to increase these volumes should there be an excess of demand.

    sugarBEAT Reception

    This order is a testament to the positive feedback garnered by the soft launch of the sugarBEAT CGM device in the U.K., by DB Ethitronix. The licensee has set up a subscription services for diabetes management that is built on sugarBEAT technology. Feedback from users has been overwhelmingly positive, largely due to the fact that it is the only daily-wear CGM on the market that affords users the flexibility to monitor their glucose levels at their own pace, resulting in lower expenses.

    Future Outlook for NMRD

    Despite trending down consistently for several days, NMRD is poised to capitalize on its recent uptrend, which it will hope to maintain as it returns to its previous trajectory of success. Current and potential ivnestors are hopeful that management will leverage the resources at their disposal to facilitate significant and sustained increases in shareholder value.